| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $77K | +83.3% |
| R&D Expense | $2.4M | +6.2% |
| SG&A Expense | $4.1M | -9.1% |
| Operating Income | -$7.9M | +7.8% |
| Income Tax | $0 | — |
| Net Income | -$7.8M | +14.2% |
| EPS (Basic) | -$3.09 | +70.2% |
| EPS (Diluted) | -$3.09 | +70.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.8M | -12.1% |
| Accounts Receivable | $0 | — |
| Inventory | $544K | +20.0% |
| Current Assets | $3.4M | -8.9% |
| Total Assets | $6.3M | -11.4% |
| Current Liabilities | $2.2M | -3.3% |
| Total Liabilities | $3.0M | -20.5% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.9M | +18.0% |
| Capital Expenditures | $32K | +7504.5% |
| Investing Cash Flow | -$107K | — |
| Financing Cash Flow | $6.6M | -37.2% |
| Free Cash Flow | -$6.9M | +17.7% |
| $3.3M |
| -1.2% |